Privilege escalation in Philips Intellispace Cardiovascular
CVE-2018-14787
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.
Vulnerability class: Privilege Escalation
EPSS: 0.004 (31.7th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 7.8 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.
Affected products
- Philips Intellispace_cardiovascular
- Philips Intellispace Cardiovascular (Iscv) Products — versions IntelliSpace Cardiovascular, Version 3.1 or prior, Xcelera Version 4.1 or prior
- Philips Xcelera
Weakness classification (CWE)
References
- ics-cert@hq.dhs.gov (x_refsource_CONFIRM, Vendor Advisory)
- ics-cert@hq.dhs.gov (US Government Resource, Third Party Advisory, x_refsource_MISC)
Frequently asked questions
- What is CVE-2018-14787?
- CVE-2018-14787 is a high-severity vulnerability in Philips Intellispace Cardiovascular, classified under Improper Privilege Management. CVSS score: 7.8/10. Published 2018-08-22.
- How severe is CVE-2018-14787?
- High severity. CVSS v3 base score is 7.8 out of 10.